| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbbe1c35732afbee454c02e3dee87020
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3be2a4bd2e713e3645825db0b9c3405e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-323
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4727
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4712
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4722
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G06F17-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883 |
| filingDate |
2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3294e0628bb4ae904e4a24aa9d865e2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb86f879ce13447ed80844a2c23aa530
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2869437a025a4e00864cafa6e54d0b62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a89ae58d1530e7b7ee7b5f8d8f755cae |
| publicationDate |
2020-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2020115756-A1 |
| titleOfInvention |
Method for diagnosis of unstable atherosclerotic plaques |
| abstract |
The present invention relates to a diagnostic method for diagnosing unstable atherosclerotic plaque, a method for determining the probability of a subject suffering from a cerebrovascular disease, and a method for selecting a patient susceptible to being treated with a therapy for removing or stabilizing the carotid atherosclerotic plaque based on determining the expression level of at least one gene selected from the group of genes shown in Table 1. The invention also relates to a kit having reagents suitable for determining the expression levels of at least one gene selected from the group of genes shown in Table 1, and optionally reagents for determining the expression levels of one or more housekeeping genes, and uses of the kit. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111593121-A |
| priorityDate |
2017-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |